ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,706Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 617

$531K Total Retail Price of All Prescriptions

Rank: 80 out of 617

496 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 496 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 496 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 12,807 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 854 854 1 2
LEVOTHYROXINE SODIUM 655 619 2 1
LISINOPRIL 549 537 3 5
ALENDRONATE SODIUM 500 487 4 25
AMLODIPINE BESYLATE 493 468 5 6
FUROSEMIDE 471 432 6 4
WARFARIN SODIUM 433 427 7 7
METOPROLOL SUCCINATE 407 397 8 12
METOPROLOL TARTRATE 370 360 9 11
OMEPRAZOLE 312 299 10 3
ATENOLOL 300 300 11 17
HYDROCHLOROTHIAZIDE 264 264 12 13
POTASSIUM CHLORIDE 262 245 13 10
METFORMIN HCL 252 249 14 9
SERTRALINE HCL 245 197 15 20
ATORVASTATIN CALCIUM 235 222 16 14
HYDROCODONE-ACETAMINOPHEN 232 190 S3 17 8
TAMSULOSIN HCL 216 215 18 26
TRIAMTERENE-HCTZ 160 149 19 47
BENAZEPRIL HCL 128 119 20 44
CRESTOR 124 114 21 28
GLIMEPIRIDE 118 118 22 33
ALLOPURINOL 107 107 23 27
MIRTAZAPINE 106 106 24 50
LOSARTAN POTASSIUM 106 106 24 22
DIGOXIN 102 74 26 48
DONEPEZIL HCL 100 100 27 30
DIOVAN 99 99 28 41
LOSARTAN-HYDROCHLOROTHIAZIDE 96 96 29 46
FENOFIBRATE 92 92 30 58
PRAVASTATIN SODIUM 91 81 31 21
PAROXETINE HCL 89 85 32 62
CARVEDILOL 87 70 33 19
PREDNISONE 83 83 34 31
ADVAIR DISKUS 83 71 34 38
ACTOS 80 77 36 85
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 79 37 29
TRAMADOL HCL 77 74 38 15
FLUTICASONE PROPIONATE 75 72 39 36
ISOSORBIDE MONONITRATE ER 72 72 40 52
ESCITALOPRAM OXALATE 67 60 41 65
FAMOTIDINE 65 64 42 54
DILTIAZEM 24HR ER 65 65 42 162
DILTIAZEM ER 63 63 44 81
POLYETHYLENE GLYCOL 3350 63 61 44 32
GABAPENTIN 62 49 46 16
FLUOXETINE HCL 58 55 47 73
ROPINIROLE HCL 56 44 48 66
RANITIDINE HCL 56 20 48 40
IPRATROPIUM-ALBUTEROL 55 50 50 151
NAMENDA 54 54 51 35
SYNTHROID 53 53 52 59
ZOLPIDEM TARTRATE 53 48 52 23
ENALAPRIL MALEATE 52 41 54 34
SYMBICORT 51 45 55 141
CITALOPRAM HBR 51 51 55 18
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 8, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.